Skip to main content
  • Early Trial Data Suggest Edwards Lifesciences’ EVOQUE System Is Safe and Effective in TTVR

    Data from two separate studies suggest the transfemoral EVOQUE system for transcatheter tricuspid valve replacement (TTVR) has acceptable safety and durable efficacy at both 30-day and 1-year follow-up.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details